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Abstract  
Exposure of humans and wildlife to chemicals via food, consumer products, the 
environment etc. can imply exposure to an infinite number of different combinations of 
chemicals in mixtures. It is practically impossible to test all these possible mixtures 
experimentally and it is therefore needed to find smart strategies to assess the potential 
hazards using new tools that rely less on in vivo testing and incorporate instead 
alternative experimental and computational tools. In this report the current state of the 
art for the application of these alternative tools for assessing the hazard of chemical 
mixtures is briefly reviewed. The focus is hereby on the adverse outcome pathway (AOP) 
concept, in vitro methods, omics techniques, in silico approaches such as quantitative 
structure activity relationships (QSARs) and read-across, toxicokinetic and dynamic 
energy budget (DEB) modelling, and on integrated approaches to testing and 
assessment (IATA).  
Furthermore, an expert survey was performed to collect up to date information and 
experience on the current use of different approaches for assessing human and 
environmental health risks from exposure to chemical mixtures, with a view to informing 
the development of a consistent assessment approach. An online survey was performed 
among experts in the field of combined exposure assessment in the period of January to 
March 2014, addressing both, human health and environmental risk assessment. Fifty-
eight experts from 21 countries, different stakeholder groups and sectors of legislation 
participated in the survey. The main sectors where most experience is already gained in 
assessing mixtures are in the area of plant protection products and chemicals under 
REACH. These were also rated highest regarding the priority for performing mixture 
assessments. Experts have experience with the whole mixture as well as the component-
based approaches applying them to both, intentional and unintentional mixtures. Mostly 
concentration addition (CA) based methods are used for predicting mixture effects. 
Regarding the use of novel and alternative tools in the risk assessment of mixtures, 
expert opinions are split between those applying them (often more in a research 
context) and those that generally think these tools are valuable but their use is currently 
limited because of lack of guidance, lack of data, or lack of expertise. A general need for 
clear guidance for combined exposure assessments was identified. 
Overall, a high potential in applying novel tools and scientific methodologies for the 
assessment of chemical mixtures can be identified. They allow deriving meaningful 
information on individual mixture components or whole mixtures, enabling a better 
understanding of the underlying mechanisms of mixture effects. Their main strengths lie 
in their integrated use and smart combination to put different aspects regarding the 
hazard from combined exposure to multiple chemicals into context. In order to benefit 
from these tools in the hazard assessment of mixtures, more guidance on their use is 
needed to facilitate a more widespread application. 
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1. Introduction  
Humans and the environment are continuously exposed to a multitude of substances via 
different routes of exposure. Some of these chemical mixtures are intentional and thus 
have a known composition, e.g. personal care products, food additives and pesticide 
formulations. However, in many cases, mixtures are unintentional and (largely) of 
unknown composition, e.g. the combination of substances in surface water, drinking 
water and air.  
While many pieces of EU legislation are in place to protect humans and the environment 
against adverse effects of chemicals including mixtures, in many cases it remains 
unclear how to consider the combined exposure to chemical mixtures in the risk 
assessment. Current regulatory requirements do not generally address the exposure to a 
single substance by multiple pathways and routes of exposure, following its possible 
different uses (i.e. the so-called "aggregate exposure"). Exposure to multiple 
components from one or different exposure pathways (i.e. combined exposure) might 
also pose a health problem even if the individual components are present at levels below 
their respective NOAELs (No Observed Adverse Effects Levels), as these levels are 
derived from single compound testing. However the different existing legislations do 
often not take into account such risks or do not provide clear guidance on how to 
perform risk assessment for aggregate and combined exposures. A detailed review of 
regulatory requirements and related guidance can be found in Kienzler et al. (2014). 
In order to reflect the actual exposure scenarios, there is a need to develop a consistent, 
cross-sectorial approach to deal with the combined exposure to multiple chemicals. In 
order to develop such a harmonised approach it is important to consider the current 
scientific state of the art in this area. The objective of this report is to give an overview 
of the current practices, tools and scientific developments in assessing risks from 
combined exposure to chemical mixtures. For this purpose, the report provides some 
general background information (Section 2), a brief overview of new scientific tools in 
relevant areas of (eco)toxicology based on current literature (Section 3) and presents 
the results of a recent survey among experts in the field of mixture risk assessment 
(Section 4). 
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2. Introduction to main concepts and terminology in the 
assessment of mixtures / effects from combined exposure  
The hazard of chemical mixtures can be assessed as a whole (whole-mixture approach), 
or based on the individual components of the mixture (components-based approach). 
Whole mixture effects can be assessed by testing the mixture itself, but can also be 
based on data generated with a mixture of similar composition (i.e. close in composition 
regarding components and proportions). If adverse effects are found in relevant toxicity 
studies, a quantitative assessment can be carried out directly from these data. This 
approach allows consideration of any unidentified materials in the mixtures and any 
interactions among mixture components, but it does not identify the chemicals 
responsible for the mixture effects or interactions, and does not provide any information 
on the toxicity of individual mixture components. Moreover, this approach is restricted to 
mixtures that do not significantly change in their composition, and is therefore not 
recommended as a general approach (SCHER, SCCS, SCENIHR, 2012). 
Another approach, which is generally used when the components of the mixture are 
known, is to mathematically predict the combined action of the components. The choice 
of the mathematical approach to use depends mainly on considerations whether the 
mixture components act by the same mode of action (MoA) or whether they are acting 
independently (Groten et al., 2001). Its optimal use is therefore dependent on the 
knowledge of the composition of the mixture and the corresponding MoA of the 
individual components, or on the information regarding their association with groups of 
chemicals demonstrating similar or identical MoA (assessment groups). Such information 
may be based on chemical structures and structure-activity relationships (either 
qualitative or quantitative), molecular modelling, structural alerts or on toxicological 
responses or effects (SCHER, SCCS, SCENIHR, 2012).  
Three basic types of action for combination of chemicals are usually addressed by: (i) 
dose or concentration addition (CA), applied to substances with a similar MoA; (ii) 
independent action (IA) or response addition, applied to substances with a dissimilar 
MoA; and (iii) interactions between substances in the mixture. The term interaction 
includes all forms of joint action that deviate from the above additivity concepts. Hence, 
the combined effect of two or more substances is either greater (synergistic, 
potentiating, supra-additive) or less (antagonistic, inhibitive, sub-additive, infra-additive) 
than that predicted on the basis of dose addition or response addition. Both, CA and IA, 
are based on the assumption that substances do not influence each other's toxicity by 
interacting at the biological target site, and they have been suggested as default 
approaches in regulatory risk assessment of chemical mixtures (SCHER, SCCS, 
SCENIHR, 2012), although chemical mixtures are rarely composed of either only 
similarly or of only dissimilarly acting substance. SCHER, SCCS, SCENIHR (2012) 
recommend applying CA if no MoA information is available, as it is regarded as more 
protective. 
Another way of addressing risks form combined exposure is to apply an additional 
mixture assessment factor (MAF), which could be easily implemented in single substance 
RA. Detailed information on the ongoing discussion can be found in Backhaus (2015). A 
generally applicable MAF is hard to find due to the huge variety in mixture scenarios and 
the need to be protective but not overly conservative. Therefore, Backhaus (2015) 
investigated further possibilities to develop a protective MAF concept based on 
addressing the most important uncertainties that are supposed to be covered by a 
suitable MAF. These uncertainties are incomplete knowledge of the mixture composition 
(compounds and concentrations), incomplete knowledge on hazard of mixture 
components, possible synergistic interactions, and uncertainties related to the sole use 
of CA. An exercise was performed to consider four different exposure scenarios with 
mixtures of 15-42 components. It was observed that single substance RA and risk 
management and mitigation significantly lowered the risk of the mixture, however was 
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insufficient to ensure protection against mixture effects. The Maximum Cumulative Ratio 
(Price and Han, 2011) resulted as an adequate approximation for a MAF, which ranged 
from 2 to 17 in the investigated examples, highlighting the need for considering specific 
exposure scenarios. A scheme is suggested to determine the value of MAF depending on 
the information available on the mixture (e.g. known number of components of the 
mixture, information on individual risk quotients of the components, information on 
interactions). Applying a MAF in the RA of single substances is however difficult since 
appropriate risk management and risk mitigation measures might need to be developed 
for scenarios in which many actors contribute to an overall risk with chemical emissions 
that individually have a risk quotient below 1. The conclusion of the report is that the 
risk quotient of an individual chemical should not only be viewed as a measure of risk in 
itself but also as a measure of the contribution of the compound to the overall risk and a 
combined exposure scenarios, overcoming the concept that chemicals with a risk 
quotient below 1 are automatically safe even in complex exposure scenarios.  
For further information on the underlying concepts please refer to e.g. Kortenkamp et al. 
(2009), SCHER, SCCS, SCENIHR (2012) or Kienzler et al. (2014). Here, recent literature 
regarding the approaches for mixtures of similarly and dissimilarly acting compounds are 
further addressed, as well as regarding the considerations of interactions in the risk 
assessment of chemical mixtures. 
2.1. Similar vs dissimilar mode of action (MoA) and grouping of 
chemicals 
As mentioned above, usually mixtures of components with similar MoA are addressed 
based on the concept of concentration addition (CA) and compounds with different MoA 
are addressed based on the concept of independent action (IA). For deciding on the right 
concept, the distinction of (dis)similar MoA and the related grouping of chemicals in a 
mixture are crucial. Typically two main approaches are used for deciding if mixture 
components act in a similar or dissimilar way and to perform related groupings of 
mixture components: (1) investigating whether components follow a common MoA, or 
(2) whether they elicit common phenomenological effects or affect the same target 
organs. 
EFSA's PPR Panel (2014) developed a methodology for forming cumulative assessment 
groups (CAGs) for pesticides in the context of setting maximum residue levels for 
pesticides in food. The proposed methodology follows a phenomenological approach 
based on organ or system toxicity. Thus all pesticides causing a specific effect are 
included in one CAG even if the underlying MoA is unknown. Due to the low exposure 
levels of residues, interactions are not expected to occur and the PPR Panel based the 
approach on concentration addition. EFSA's PPR Panel (2013) further discussed the 
assessment of pesticides with dissimilar MoA, however restricting its considerations to 
substances with dissimilar MoA but common adverse effects on the same organ or 
system. The PPR Panel concluded from the reviewed literature that no case showed more 
conservative predictions of combined toxicity using IA based approaches where at the 
same time the predictions were also more accurate than based on CA. The use of IA for 
predicting combination effects requires demonstration that modes of action of individual 
substances in a mixture are strictly independent, a condition that can rarely be met in 
practice. In addition, CA can be applied with existing data and has less data 
requirements than IA (Kortenkamp et al., 2009). The PPR Panel therefore recommended 
using cumulative risk assessment methods derived from CA also for the assessment of 
mixtures of pesticides with dissimilar modes of action, provided they produce a common 
adverse outcome. 
Junghans et al. (2006) investigated the suitability of the two concepts of CA and IA to 
predict the combined effects of realistic environmental mixtures. The exercise was 
performed on a realistic exposure scenario for agricultural field run-off water considering 
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25 pesticides. Effects on the reproduction of the freshwater algae Scenedesmus 
vacuolatus were well predicted by CA, in accordance with the finding that toxicity was 
dominated by a group of similarly acting photosystem II inhibitors, even if the mixture 
included also pesticides with diverse and partly unknown MoA. Predictions based on IA 
slightly underestimated mixture toxicity, however, the difference in predictions based on 
CA and IA was rather small (factor of 1.3). The authors concluded that CA provides a 
precautionary but not overprotective approach for combined effect predictions of 
pesticide mixtures under realistic exposure scenarios, irrespective of the similarity or 
dissimilarity of their mechanisms of action. 
Apart from the combined effects of pesticides, the combination effect of endocrine 
disruptors is relatively well researched. Kortenkamp (2007) reviewed literature on 
combination effects of endocrine disruptors (EDs). Examples in the literature clearly 
demonstrate that combinations of EDs with similar effects are able to act together at 
doses that when used alone do not lead to observable effects. The experimental 
evidence is in line with the assumption of dose addition. For EDs it seems best to follow 
a phenomenological approach to produce workable grouping criteria. There are 
arguments against using a toxicity equivalency factor (TEF) approach or other CA based 
approaches for EDs since it would ignore potential interactions, however, there is 
overwhelming evidence showing that groups of estrogenic, anti-androgenic, and thyroid-
disrupting chemicals act together in an additive way. For the time being it is proposed to 
group EDs according to their ability to provoke similar effects rather than according to 
similar mechanism of action. Given that the TEF concept unrealistically assumes parallel 
dose-response curves it should not be used. Dose addition should be preferred for 
calculating quantitative additivity expectations. Further research might trigger 
adaptations to such a temporary approach. Comparatively little is known about 
combined effects of EDs belonging to different classes, how these might interact and 
produce combined effects. Also combinations with chemicals which are not producing the 
same effects under analysis but that can modulate the effects of other chemicals should 
be investigated further since such effects cannot be predicted by CA. It should be 
explored whether the direction of modulation could be anticipated qualitatively e.g. by 
analysing interaction at the level of metabolism and transport. Further research should 
particularly focus on combinations of EDs that belong to different categories. 
Apart from most of the recommendations and current practices of focusing on combined 
effects on chemicals with similar MoA, recently also the relevance of combinations of 
dissimilarly acting compounds was highlighted. Based on the relatively well studied 
adverse effects of mixtures of pharmaceuticals, Hadrup (2014) suggested that chemicals 
with dissimilar mechanisms of action could be of bigger concern in the toxicological risk 
assessment of chemical mixtures than chemicals with a similar mechanism of action. 
Examples such as e.g. in cancer and HIV treatment, show that pharmacological 
combination therapy targeting different mechanisms of action is more effective than a 
strategy where only one mechanism is targeted. Another argument is that also in many 
diseases several organ systems concomitantly contribute to the pathophysiology, 
implying that a grouping based on common target organs may be inadequate. In further 
considerations, it should be however considered that in pharmacology usually higher 
doses are applied, whereas at lower concentrations some specific effects might not 
occur. 
Goodson et al. (2015) reviewed actions on key pathways and mechanisms related to 
carcinogenesis for 85 chemicals. The analysis suggested that the cumulative effects of 
individual (non-carcinogenic) chemicals acting on different pathways and a variety of 
related systems, organs, tissues and cells, could in combination produce carcinogenic 
synergies. Additional basic research on carcinogenesis and low-dose effects of chemical 
mixtures is needed. However, the concept of assessing combined effects strictly based 
on grouping chemicals according to their MoA/AOP, might need to be revisited in order 
not to underestimate cancer-related risks. Risk assessment for combined exposure 
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should consider synergies of chemicals acting via dissimilar processes, acting on 
different targets and tissues, and consider synergies between certain pathways. 
Overall, evidence in the literature supports the application of concentration addition as a 
first, protective approach. It is therefore also the default approach to start from in 
several international recommendations and frameworks, independent of components' 
similar or dissimilar mode of action. However, once a detailed risk assessment for a 
mixture is performed, chemical grouping should be considered and based on common 
target organs and/or common mode of action (MoA). The choice of the approach 
depends strongly on the context of the risk assessment as well as on the information on 
which to base the grouping of components. Irrespective of the starting point for 
grouping, it is recommended to use all available information on the mixture and its 
components: physico-chemical properties, structural alerts, (Q)SAR and read-across 
information, evidence from omics, in vitro (high throughput screening or other) or in 
vivo experimental data, depending on availability. 
2.2. Interactions 
Toxicological interactions modulate toxicokinetic and/or toxicodynamic mechanisms of 
individual chemicals. Toxicokinetic interactions could be e.g. induction of metabolising 
enzymes, alterations in uptake mechanisms, all processes linked to influence of 
individual chemicals on ADME of others. Toxicodynamic interactions can be based on e.g. 
modulation of homeostasis or repair mechanisms. 
Boobis et al. (2011) performed a literature review, identifying 90 studies demonstrating 
synergisms in mammalian test systems performed at low doses (i.e. close to the point of 
departure, POD) for individual chemicals. Only in 6 of the 90 studies useful quantitative 
information on the magnitude of synergy was reported. In those six studies the 
difference between observed synergisms and predictions by CA did not deviate by more 
than a factor of 4. 
Cedergreen (2014) performed a systematic literature review for binary mixtures within 
three groups of environmentally relevant chemicals (pesticides, metals, antifouling 
agents). Synergy was defined as a minimum two-fold deviation from CA predictions. 
Synergy was found in 7%, 3% and 26 % of the pesticide, metal and antifoulant 
mixtures, respectively. The extent of synergy was rarely more than factor of 10. Based 
on some more in depth analysis Cedergreen concluded that true synergistic interactions 
between chemicals are rare and often occur at high concentrations. Using standard 
models as CA is regarded as the most important step in the RA of chemical mixtures. 
Kamo and Yokomizo (2015) performed a modelling exercise addressing three theoretical 
scenarios of non-interacting chemicals, directly and indirectly interacting chemicals. The 
results showed that combined effects obey CA only when the MoA of the components of 
the mixture are exactly the same. However, nonlinear effects vanished when the 
chemical concentrations were low, suggesting that the current management procedure 
of assuming CA is rarely inappropriate because environmental concentrations of 
chemicals are generally low. 
Approaches to address interactions and unravel the mechanisms are shown e.g. in 
sections 3.6 and 3.7. In guidance by ECHA (2014) for biocidal products and EFSA's PPR 
Panel (2013) for pesticides, a deviation between CA predictions and measured mixture 
toxicities by a factor of 5 or more is regarded a synergistic/antagonistic interaction which 
has to be considered further. More generic approaches to address interaction in mixture 
hazard assessments look at the use of classical CA based methods and adding an 
additional safety factor to account for possible (unidentified) interaction effects. This 
might be an option for specific cases and compound classes as discussed e.g. in 
Backhaus et al. (2013), where an interaction factor of 2 for biocidal mixtures is proposed 
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based on the evidence that in the majority of cases synergistic effects will not lead to 
higher deviations from CA prediction.  
Overall, evidence in the literature indicates that the interactions at lower concentration 
levels such as environmental concentrations are rare and if observed, leading to 
deviations from CA predictions that are relatively small. However, more knowledge could 
be gained from additional case studies covering different sectors to further underpin this. 
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3. New scientific tools for hazard assessment and how they 
could be used for assessing mixtures/effects from 
combined exposure 
Exposure of humans and wildlife to chemicals via food, consumer products, the 
environment etc. can imply exposure to an infinite number of different combinations of 
chemicals in mixtures. It is practically impossible to test all these possible mixtures 
experimentally, especially in vivo. Therefore, smart strategies are needed to assess the 
potential hazards using new tools that rely less on in vivo testing and incorporate instead 
alternative experimental and computational tools. These tools are ideally simpler, faster, 
and more robust in providing the necessary toxicological information of defined and /or 
undefined mixtures.  
In the following the applicability, benefits and limitations of the main current methods 
and concepts are discussed in the context of hazard assessment of mixtures based on 
recent literature. 
3.1. Adverse Outcome Pathways (AOPs) 
The Adverse Outcome Pathway (AOP) methodology is an approach which provides a 
framework to collect, organise and evaluate relevant information on chemical, biological 
and toxicological effects of chemicals. This approach supports the use of a mode (and/or 
mechanism) of action basis for understanding adverse effects of chemicals (OECD, 
2013). The approach is based on the concept that toxicity results from the chemical first 
reaching and then interacting with an initial target or targets in the organism. Thus, an 
AOP is a sequence of events, starting from the molecular initiating event (MIE; at 
macromolecular level), via intermediate key events (KEs, at cellular or organ level) to 
the in vivo outcome of interest (adverse outcome, AO; at organism and population 
level).  
As described in the sections below, the prediction and assessment of mixture effects 
often considers mechanistic information in order to determine whether mixture 
components follow a similar or dissimilar mode of toxic action and hence should be 
assessed together or not. This is most often used in order to group mixture components 
and to decide whether to apply CA or IA based approaches for mixture effect predictions 
(Borgert et al, 2004). Ankley et al. (2010) illustrated how effects caused by mixtures of 
chemicals that act via the same molecular initiating event or affect pathways that 
converge at common intermediate steps, can be aggregated for risk characterization. 
Thus AOPs provide a valuable framework for grouping mixture components based on the 
Mode of Action (MoA) into cumulative assessment groups (CAGs). Examples in the 
literature sometimes show a grouping of chemicals based on similar target organs, but 
often follow the AOP concept even if not presented as such. When chemicals are grouped 
based on their MoA, one needs to keep in mind that depending on the dose ranges, 
chemicals might produce different effects by different mechanisms (Borgert et al, 2004), 
thus following different AOPs. Thus the mechanistic considerations need to take due 
account of the relevant exposure concentrations.  
In the Solutions project presented in Altenburger et al. (2015), water quality monitoring 
is performed by a combination of chemical and bioanalytical tools for targeted and non-
targeted screening of components in environmental mixtures. The bioanalytical tools 
should capture MIEs and KEs in order to inform about the toxic pressure in situ. Effects 
at various biological levels should be assessed (molecular, cellular, organism and 
population level), which is in line with the AOP concept. 
Using AOPs and toxicokinetic modelling, results from in vitro testing can be put into 
context and used to support mixture risk assessment with a reduced number of animal 
testing (section 3.2).  
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3.2. In vitro methods 
In vitro models usually consist of cell lines that are cultured in the laboratory under 
standard conditions. The main advantage of in vitro models is that they allow the study 
of biological responses under such controlled conditions, where in vivo models might be 
influenced by non-chemical stressors that can make the assessment of chemical induced 
effect(s) even more complex and challenging. In addition, most used cell lines can be 
cultured relatively easily, they can be used in a high throughput setting, which makes it 
possible to test for different effects and different combinations of compounds in parallel. 
As such, in vitro tools provide a pivotal role in toxicity pathway testing, as e.g. put 
forward by the NRC report on Toxicity Testing in the 21st Century: A Vision and a 
Strategy (NRC, 2007). 
Most in vitro tools currently applied in risk assessment consist of cell lines that are 
designed to respond to specific effects, so called mechanistic assays. Generally, they 
respond to the activation of receptors and/or specific pathways, as a result of e.g. 
receptor activation or triggering of cellular repair mechanisms. As such, they can be 
used to elucidate the mechanism(s) of action of a compound or combination of 
compounds. By considering the effects in a broader context, e.g. as specific steps in an 
AOP, in vitro tests can provide important information on MoA/AOP, e.g. for subsequent 
grouping of chemicals or for prioritizing compounds for risk assessment (Caldwell et al, 
2014).  
The application of in vitro tools in the assessment of chemicals mixtures can be divided 
into two approaches: top-down and bottom up. In the top-down approach, in vitro 
assays are used to assess the overall amount of toxicity, effect, receptor activation etc. 
triggered by a complex mixture. This effect-based environmental monitoring is 
increasingly being applied to assess environmental mixtures, in part because of their 
ability to give an overall response to the mixture present, and in part because the 
compounds causing the effects were – and to a large extent still are – largely unknown 
(Tang et al., 2013, 2014). Because of this, in vitro tools are also widely used in 
identifying previously unknown or unconsidered effects, but are also used to identify the 
compound(s) responsible by combining sophisticated chemical analysis with in vitro 
measurements, in a process frequently called Effect Directed Analysis (EDA) (Burgess et 
al., 2013, Beyer et al., 2014).  
While approaches like EDA start top-down, more bottom approaches are also utilized, in 
which many chemicals are screened for activity in a wide range of in vitro assays (Beyer 
et al. (2014). Several recent initiatives have been launched to profile the effects of a 
compound using a wide range of in vitro assays, like the ToxCast program from the US 
EPA, or the Tox21 by the National Institute of Health (NIH). These assays include assays 
focusing on specific pathways or effects, e.g. mitochondrial toxicity (Attene-Ramos et al., 
2013a), cell viability and nuclear receptor assays including hormone receptors and 
metabolic pathways (Huang et al., 2011) and various other endpoints (Tice et al., 2013). 
While many of these initiatives initially focused on environmental chemicals, these 
approaches are promising for all chemical risk assessment of many compounds, 
including pharmaceutical, personal care products and food ingredients (Rovida et al., 
2015). Regardless of the approach, linking the total mixture toxicity measured in vitro 
tools to compound concentrations is dependent on the mathematical model that is used 
to describe the overall predicted effects based on individual concentration. Similarly, in 
vitro tools can be used to assess the validity of specific models to predict mixture 
effects. 
A major hurdle in the acceptance of results obtained by in vitro tools is the question how 
to translate in vitro findings to adverse in vivo effects (which is the actual protection 
goal). As in vitro studies generally cannot take into account some of the complexity of 
the whole organisms, including uptake, metabolism and feedback mechanisms, in vitro 
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to in vivo extrapolation (IVIVE) is currently an important research topic (see e.g. 
Adeleye et al., 2015). While in vitro assays can provide important information regarding 
the mode of action (the toxicodynamics), better predictions can be obtained by 
extrapolating the in vitro exposure conditions to the in vivo situation using toxicokinetic 
models (see section 3.6). Single in vitro assays cannot cover all the parameters 
necessary to make the translation to in vivo. Dedicated in vitro assays can help in 
identifying and quantifying the parameters needed to validate the uptake, metabolism 
and excretion models needed for the in vitro to in vivo translation. 
While it is difficult to predict the actual in vivo effects based solely on in vitro 
concentrations, in vitro tools might be used for regulatory screening purposes by relying 
on a threshold (both human and environmental) below which relevant effects are not 
expected to occur in vivo. Different approaches have been put forward, mainly focusing 
on endocrine pathways (Brand et al., 2013, Jarosova et al., 2014, Escher et al., 2015). 
Based on their ability to predict in vivo or chemical analysis results (Browne et al., 2015, 
Sonneveld et al., 2006), several in vitro tools are accepted by regulatory bodies for the 
assessment of single compounds and mixtures. E.g. the US EPA is currently considering 
the acceptance of ToxCast ER model data as alternative for the in vivo Uterotrophic 
Assay (Browne et al, 2015). Some regulation do already allow for the use of in vitro 
assay measurements for mixtures. For example, EU regulations 589/2014 and 709/2014 
specifically allow the use of in vitro methods to give an indication of the total TEQ level 
in food and feed respectively, expressing the results as Bioanalytical Equivalents (BEQ), 
rather than the calculated TEQ based on individual congener concentrations analysed 
chemically. 
3.3. Omics 
Omics techniques allow a global analysis of gene transcripts (transcriptomics, also called 
gene expression profiling), of proteins (proteomics) and of small molecule metabolites 
(metabolomics) including their relative abundance (see e.g. Schirmer et al 2011; 
Villeneuve and Garcia-Reyero 2011). Omics are suitable to study effects at low doses 
which are more relevant for environmental mixture exposure due their high sensitivity. 
However, the effects observed at omics level need to be interpreted with care since the 
molecular responses do not necessarily lead to an adverse outcome at the physiological 
level (Borgert 2007; Beyer et al 2014). Furthermore, mechanistic information on the 
mode of toxic action and affected pathways can be derived, which makes the tools 
valuable in the context of mixture toxicity as well as single substance toxicity 
investigations.  
Altenburger et al (2012) reviewed literature on the application of omics techniques in 
investigations of chemical mixtures. Among the 41 studies found (published 2002-2011), 
most were transcriptomics studies. Many studies investigate the mode of action of single 
substances and try to predict responses upon exposure to chemical mixtures. Omics 
techniques can help identifying toxicological mechanisms of individual compounds by a 
non-biased discovery driven approach (Beyer et al 2014). They can facilitate the 
identification of key molecular events and complex sequential events caused by 
stressors. They can support building a more complete overview of stress-response 
profiles (e.g. toxicity pathways), both for single stressors and mixtures; identify key 
MoAs; to mechanistically understand the potential for interactions between mixture 
components; the selection of robust biomarkers for mixture prediction models in ERA.  
In the reviewed literature, Altenburger et al (2012) found no clear relationship between 
the exposure doses, the number of chemicals in a mixture and the number of related 
affected gene responses. In some cases responses of specific pathways upon exposure 
to individual compounds were replaced by more general stress response upon exposure 
to mixtures. However, by delivering more mechanistic information also on individual 
components, omics results can help in generating hypotheses on possible interactions 
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between mixture components (El-Masri, 2007). This can feed into the development of 
mechanistic models used to simulate results that can be tested by model-designed 
experiments. Dardenne et al. (2008a) used multi-endpoint bacterial gene profiling in 
combination with cluster and principal component analysis in order to explore to what 
extent compounds can be grouped according to their toxicological mechanism of action. 
Several clusters of MoA could be identified and results be improved by combining 
different clustering techniques. Projection of two environmental samples in the principal 
component analysis (PCA) plane allowed identifying the mixed mode of action of these 
samples, which can be useful for deriving first information on samples of unknown 
composition. 
Several studies try to also quantitatively interpret the data, using the concepts of 
concentration addition and independent action as is usually done for apical endpoints. 
The major limitation for applying these concepts to omics studies is the usually limited 
number of tested concentrations (Altenburger et al., 2012). Another limitation that 
hampers the application of a classical toxic unit approach, is the difficulty of deriving 
effect concentrations (ECx) since the maximum induction levels for different genes vary 
with different chemicals (depending e.g. on the cytotoxicity of a specific compound) 
(Dardenne et al., 2008b). Dardenne et al. (2008b) investigated the effects of individual 
substances and binary mixtures on 14 stress gene promoters. Mixture responses were 
fitted applying both, CA and IA models. In many cases both models were able to predict 
the mixture response from the individual compound responses. Differences between CA 
and IA predictions were rather small. Deviations from CA and IA occurred, sometimes 
with deviations being in opposite directions (i.e. synergistic or antagonistic) at high and 
low dosage level. The choice of the best fitting model could not be made objectively 
based on similar or dissimilar mode of action.  
In summary, to date the major benefit of applying omics in the context of mixtures is to 
use them for unravelling MoAs of the individual components in order to group them and 
facilitate appropriate predictions of mixture toxicity. 
3.4. Quantitative Structure-Activity Relationships (QSARs) 
Quantitative Structure-Activity Relationship (QSAR) models can be used to obtain 
information on the properties and activities of substances based on their chemical 
structure alone, and can thus be used to fill data gaps in the safety assessment of 
chemicals. Predictive approaches, such as QSARs, are essential for estimating mixture 
toxicity as the number of possible mixtures is extremely large (Kim and Kim, 2015). 
There are three main ways in which QSARs can be applied for the assessment of 
mixtures: (1) for predicting (missing) information on individual compounds (physico-
chemical properties, toxicological effects) (2) for predicting directly or stepwise the 
combined effects and interactions of chemicals in a mixture (3) for assessing whether 
chemicals will act in a similar or dissimilar way to perform their grouping. 
Altenburger et al. (2003) outlined how QSARs could support mixture toxicity evaluations. 
All organic compounds (also those with specific MoA), will exert baseline toxicity 
resulting from non-specific effects, related to partitioning into membranes and 
adsorption to macromolecules. Thus all organic chemicals will contribute in an additive 
way to baseline effects of a mixture also at very low concentrations. Thus a mixture will 
be at least as toxic as corresponds to the sum of the fractional baseline toxic 
concentrations of the components. This holds true however only in the absence of 
antagonism that could result from metabolic detoxification of some components induced 
by other components of the mixture. In a mixture with differently acting chemicals, 
specific effects might not be triggered due to very low concentrations of the individual 
components. However, their contributions to baseline toxicity will remain and might add 
up to overall significant effects of the mixture. QSARs can therefore be used to predict 
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the baseline toxicity of a mixture and when comparing to measured toxicity of a mixture 
help identifying if specific effects were occurring in addition.  
Altenburger et al. (2003) also found that it is sometimes assumed that if one QSAR can 
be applied to predict the toxicity of all mixture components, the compounds will by 
default follow CA. However, this is not always the case since compounds may contribute 
to different extent to narcotic and specific toxicity in a QSAR. Therefore, this assumption 
is not generally valid. 
When comparing experimentally measured mixture toxicities with those predicted by 
QSARs, deviations observed were bigger for binary mixtures than for multiple mixtures 
(Altenburger et al., 2003). This might be due to greater experimental variability for more 
complex mixtures as well as due to an increasing degree of compensation of deviations 
with increasing number of components in the mixture.  
Direct prediction of mixture toxicity by QSARs is rather rare. It is only possible if the 
detailed mixture composition is known. In some cases (Altenburger et al 2003), 
predicted mixture toxicity is higher than experimentally determined, mainly due to 
inadequate predictions for some individual components. If predictions are based on 
observations at higher concentrations, this can lead to overestimations of toxicity, since 
at low concentrations the specific effects of some compounds may not be triggered yet 
(e.g. in the case of pesticides) and hence they act as nonspecific toxicants. If the 
mixtures are composed of compounds that are predicted adequately individually, also 
the joint toxicity is mostly predicted with a sufficient degree of accuracy.  
QSARs can be used to discriminate classes of toxicants, i.e. to assess mixture 
components for similar or dissimilar mode of action. QSAR-based tools to look for 
functional similarities comprise molecular indices, topological indices and atom pairs, 
physicochemical and quantum chemically derived stereoelectronic descriptors, together 
with subsequent discriminant analysis. A sequential analysis applying the different 
approaches can enhance the predictive capacity when dealing with several different 
classes of chemicals (Altenburger et al., 2003). For example, Mwense et al. (2006) use a 
set of molecular descriptors to determine the overall structural similarity and 
dissimilarity within a mixture based on all the pairwise similarities and dissimilarities 
between the constituent molecules. Then the degree of similarity vs dissimilarity is used 
to weight the relative contributions of concentration addition and independent action in a 
mathematical model based on both approaches.  
QSARs can be used for modelling exposure concentrations and have been proposed for 
calculating internal exposure concentrations by modelling internal distribution and 
metabolism (Altenburger et al., 2003). This is especially important when chemicals are 
reactive or interacting with protein macromolecules. For example, Verhaar et al (1997) 
illustrated an approach to assess the toxicity of complex multi-component mixtures, 
where QSARs can provide input parameters for PBPK models and a lumping analysis to 
reduce mixture complexity to a limited number of compound categories.  
Kim and Kim (2015) reviewed recently developed computational methods based on 
QSARs for predicting mixture toxicity in environmental risk assessment (ERA). They 
searched for related peer-reviewed articles published 2011-2013 in the fields of 
toxicology, environmental science and ecology and engineering. They identified empirical 
QSARs developed mainly based on partition coefficients. In the case of single substance 
QSARs these are usually based on Kow, in the case of mixtures it is proposed to base 
them on Kmd (i.e. the C18 EmporeDisk/water partition coefficient of the mixture). Kmd was 
found to be promising for predicting the mixture toxicity of some chemicals (halogenated 
benzenes, phenols, petroleum, PCBs, organochlorines, herbicides). However, these 
QSARs can only assess EC50s of non-interacting mixtures ignoring synergistic effects. 
Tang et al. (2013) proposed an approach for deriving effect based water quality trigger 
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values. Trigger values are derived in two steps, firstly estimating the individual 
chemicals EC50 for non-specific MoA/baseline toxicity by QSARs and secondly calculating 
mixture toxicity by CA. This represents a strategic approach to quantitatively derive 
reference concentrations of mixture toxicity of different pollutants regulated by water 
quality guidelines. Also non-empirical QSARs based on quantum chemistry and molecular 
docking processes were identified. Quantum-based QSARs based on atomic charges 
were developed that allow the prediction of mixtures at non-equitoxic concentrations of 
the components. Two-step models are available that first assign chemicals via structural 
similarity to relevant MoA and then calculate the toxicity for similar chemicals based on 
CA and in a second step for the dissimilar groups based on IA. 
In summary, QSARs can provide valuable input to assessing the toxicity of mixtures. 
Some general challenges and limitations for application of QSARs to predict mixture 
toxicities remain: 
1. The principal difficulties in dealing with mixtures, limit the quantitative application of 
QSARs in environmental field research (Altenburger et al., 2003). The restrictions 
mostly relate to the characterization of proper QSAR input parameters, since so far 
the impact of molecular properties on the mode of interaction in mixtures is 
essentially unknown.  
2. QSARs to date mainly use CA for mixture toxicity prediction; interactions (especially 
synergisms) need to be further addressed. The lack of quality data (on molecular and 
biological mechanisms) to increase understanding of synergism is essentially the 
most critical challenge in modelling it. Molecular docking based QSAR models have 
the potential to contribute to the prediction of synergisms. The main influencing 
factors for synergisms are bioavailability, internal transportation, metabolization, 
binding at the target site and excretion. Thus molecular docking theory seems most 
promising to address this (Kim and Kim, 2013). 
3. Most current QSAR developments focus on binary mixtures, QSARs enabling the 
assessment of multi-component mixtures need to be further developed. Only two out 
of eleven reviewed QSAR models were able to address multi-component mixtures 
(Kim and Kim (2015). 
4. It is important to acknowledge that the combined effect can be rather different when 
considering predictions based on EC50 values instead of considering low dose effects 
at concentrations below the NOEC (Kim and Kim, 2015). This is supported by the 
observation that at low concentrations, the specific effects of these compounds may 
not be triggered yet and hence they act as nonspecific toxicants (Altenburger et al. 
2003). Most QSAR models for mixtures predict an EC50 for the mixture, which is 
probably not relevant for environmental exposures. QSAR models that are able to 
predict multi-point estimates around threshold effect levels should be developed 
(Kim and Kim, 2015).  
5. Most current QSARs for mixtures focus on acute rather than chronic toxicity. QSARs 
based on molecular docking might help to improve chronic predictions, but at the 
moment are only able to predict toxicity for binary mixtures (Kim and Kim, 2015). 
Nevertheless, descriptive QSARs can be very useful for deriving basic understanding of 
relevant interactions and molecular mechanisms. They can help in designing and 
interpreting studies to link biological effects with chemical analysis (Altenburger et al 
2003). 
3.5. Read-across 
In the following some general principles of read-across and specific issues to consider 
when applying read-across to mixtures will be briefly discussed. For more detailed 
general considerations please refer to the OECD Guidance on Grouping of Chemicals 
(OECD, 2014) or to the ECHA Read-Across Assessment Framework (ECHA, 2015). 
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Read-across is a technique that allows predicting endpoint or test information for a 
chemical (target chemical) based on the information available on the same endpoint or 
test for one or more similar chemicals (source chemical(s)) (OECD, 2014). Two main 
approaches for read-across are usually distinguished, i.e. the analogue and the category 
approach. The analogue approach is usually used to read-across between a small 
number of similar chemicals, in a simplest case from a single source chemical to a target 
chemical. The category approach is usually applied to read-across between/within whole 
groups of similar chemicals, mostly used for structurally similar groups of chemicals and 
chemical families (ECHA, 2015).  
Read-across can be applied for the prediction of various properties in order to fill data 
gaps on e.g. physico-chemical properties, environmental fate, human health effects and 
ecotoxicity. Read-across can be performed in a qualitative or quantitative way. 
Qualitative predictions usually address the absence or presence of a certain property or 
activity. Quantitative read-across instead predicts a value for a certain property or 
endpoint, e.g. a dose-response relationship and effect concentrations (such as NO(A)EL, 
LO(A)EL) (OECD, 2014). 
The basis for read-across from one or more chemicals to another chemical or a group of 
chemicals is the similarity in structure, properties and activities of the involved 
chemicals. Structural similarity provides a convenient means of identifying likely 
analogues. Similarity may be based on common functional groups, common chemical 
class, or common precursor or breakdown products (i.e. similar metabolic or degradation 
pathway). In addition to forming groups based on structural similarity, groups can be 
further developed based on biological information. The adverse outcome pathway (AOP) 
framework (see section 3.1) can help to group chemicals according to the molecular 
initiating events (MIEs) or key events (KE) that they trigger. For this purpose it is not 
needed that the whole sequence of events of an AOP is known, however, a reasonable 
link needs to be made with the adverse outcome that is to be predicted by read-across 
(OECD, 2014). 
Read-across can be of value in the assessment of mixtures mainly in two ways: 
• Read-across for untested constituents of a mixture in a component based 
approach.  
• Read-across for similar mixtures in a whole mixture approach. 
For the first case, approaches as described above can be followed for the individual 
mixture components. In mixtures of structurally diverse compounds, read-across for 
several constituents might be an option. In cases of mixtures of substances of one 
chemical class, a category approach might be followed to read-across among different 
components of the class for which less information is available. An example is presented 
for phthalates by Health Canada/Environment Canada (2015).  
An example for the second case is the application of read-across to complex substances 
such as MCS (Multi-Constituent Substances) and UVCBs (substances of Unknown or 
Variable composition, Complex reaction products or Biological material). However, read-
across is limited to substances with sufficient knowledge about the composition (identity 
and properties of constituents) and understanding of key structures that are determining 
the mixture's behaviour. Category members are often grouped based on how these are 
manufactured, defined and used, which can provide boundaries for the constituents 
chemical space (OECD, 2014).  
The OECD QSAR toolbox is a software application that allows identifying and filling of 
data gaps for chemical hazard assessment. It comprises (eco)toxicological experimental 
data and prediction tools which can be used for grouping of chemicals and data gap 
filling (for details see OECD, 2009 and webpage with related tutorials). The OECD 
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toolbox allows also the assessment and prediction of mixtures if the chemical 
components are known. One can enter the individual components, gather the available 
experimental data on certain endpoints for the individual components and the toolbox 
can provide a prediction of the endpoint for the mixture giving the choice of similar or 
different MoA consideration. Thus this tool allows performing data gap filling by read-
across and mixture endpoint prediction in one workflow. 
3.6. Toxicokinetic and toxicodynamic modelling 
Toxicokinetics (TK) describe the concentration and time-dependent fate of a substance 
within an organism whereas toxicodynamics (TD) describe the subsequent interaction 
with biological targets and how this may lead to adverse health effects (Bessems et al., 
2015). In the context of human health and environmental risk assessment usually the 
terminology of toxicokinetics and toxicodynamics is used, however, sometimes the terms 
pharmacokinetics (PK) and pharmacodynamics (PD) are used synonymously depending 
on the origin of the models and underlying data.  
TK/TD considerations can support the assessment of chemical mixtures in several ways 
with the main areas of application being: 
• Determination of internal exposure concentrations, e.g. enabling a relation 
between body concentrations and in vitro experiments (i.e. IVIVE, in vitro to in 
vivo extrapolations), of relevance for single chemicals as well as for chemical 
mixtures. 
• Considering the simultaneous or sequential exposure to different mixture 
components, assessing the probability that those reach the same target. 
• Predicting interactions among mixture components on TK and TD level. 
The classically applied methods based on CA and IA lack a mechanistic basis and are 
thus of limited utility for high-to-low dose or animal-to-human extrapolations. PBPK 
models allow the extrapolation between doses, routes and species. PBPK/PD models can 
also help in detecting shifts in the mechanism of action at varying doses and in 
predicting interactions and their respective thresholds (El-Masri, 2007). 
Most of the identified relevant studies available in the literature, investigate the utility of 
physiologically based (PB) PK/PD models to assess and predict interactions of chemicals 
in a mixture, i.e. looking at deviations from strict additivity. Tan et al. (2011) reviewed 
PBPK/PD modelling efforts to investigate the chemical interactions at the PK and PD 
levels. Most interactions studied to date focus on PK interactions. PK interactions mean 
that mixture components influence each other's target tissue dose. This can occur if one 
chemical in a mixture affects the absorption, distribution, metabolism or excretion 
(ADME) of other components of the mixture, e.g. by inducing or inhibiting metabolising 
enzymes, competing for transporters etc. PD interactions mean that mixture components 
influence each other's target tissue response based on one unit of target tissue dose, 
e.g. if one chemical impairs repair or homeostasis mechanisms. Examples can be found 
in Tan et al. (2011); however, most examples address higher (occupational) exposure 
where interactions are more likely to occur than at lower (environmental) exposure 
levels.  
PBPK/PD modelling is often hampered by the limited availability of input parameters. 
Verhaar et al. (1997) proposed an integrated approach using PBPK/PD modelling with 
QSAR analysis and lumping analysis to predict mixture toxicity. QSARs were used to 
derive needed input parameters for unknown chemicals, e.g. partition coefficients, 
metabolic rate constants, and pharmacodynamics parameters. Since with a higher 
number of components in a mixture this becomes rather cumbersome, they proposed to 
combine it with a lumping analysis to build categories to reduce the number of 
components of the mixture to be addressed. 
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PBPK modelling can also support cumulative risk assessment including both, exposure to 
multiple chemicals and non-chemical stressors. Wason et al. (2012) investigated the 
cumulative risk for children exposed to multiple pesticides and non-chemical stressors, 
such as dietary factors. The study developed a general framework for such approaches, 
is however, not further discussed here since the focus is on chemical stressors. 
In summary, the integration of TK in the assessment of mixture hazards is of value in 
order to generate a better mechanistic understanding and currently mostly used to 
predict and interpret interactions between mixture components.  
3.7. Dynamic Energy Budget (DEB) models 
The approach of dynamic energy budgets (DEBs) is applied in the ecotoxicology area. It 
considers toxicity as a process over time that depends firstly on the build-up of the 
internal concentration, and secondly on a hazard model that describes the adverse effect 
as a chance process, e.g. using a killing rate (Løkke et al., 2013). Compared to the 
classical approaches based on CA and IA that interpret effects on different endpoints 
separately, DEB models have the advantage that by their mechanistic basis they allow 
extrapolating experimental results to e.g. other time points, time-varying exposures, 
other mixtures, other organisms, and other (non-chemical) stressors, such as e.g. food 
limitation (Baas et al., 2010).  
DEB models mostly use few parameters which have a clear biological meaning (e.g. such 
as killing or elimination rates). In order to develop DEB models, the results of a time 
series of toxicity endpoints (e.g. data on survival) are needed, which might add extra 
costs; however, this allows some increased understanding of the underlying mechanisms 
and better predictions of mixture effects.  
The first step in the DEB model addresses toxicokinetics, to determine the internal 
concentration looking at uptake and elimination in a one compartment model. Then a 
model description of the processes in the organism follows looking at assimilation, 
maintenance, growth, reproduction, death. Resulting effects on the organism can lead to 
changes in toxicokinetics for other mixture components and are considered in a feedback 
loop. The advantage of this modelling framework is that it can be applied to a large 
variety of different species, in contrast to e.g. PBPK/PD models which are very species 
specific (Baas et al., 2010). For each component in the mixture, three toxicity 
parameters are needed: the no effect concentration, the killing rate and the elimination 
rate. In addition one extra parameter to correct for the mortality in unexposed controls 
is needed. Among different examples of applying the DEB model to binary mixtures, it 
was also proven to work for more complex mixtures. Baas et al. (2009) addressed 
effects of mixtures of 80 different compounds in surface water on Daphnia, where 92% 
of the cases were correctly predicted. Using this approach the chemicals driving the 
effects could also be identified. 
Most examples in the literature are dedicated to predicting mortality and similar 
endpoints. Studies by Jager et al. (2010, 2014) showed however that DEB modelling can 
be also applied for sub-lethal endpoints elicited by mixtures.  
In summary, for the time being DEB models are not yet regularly used in the 
assessment of mixtures. They are however a promising tool, since they look at effects in 
a more integrated and mechanistic way. However, more work has to be done to specify 
what type of information is needed to identify the various mechanisms of action, and to 
quantify the importance of a correct choice for the population effects (Jager et al., 
2014). 
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3.8. Threshold of Toxicological Concern (TTC) 
The Threshold of Toxicological Concern (TTC) is a methodology that can be applied to 
assess potential human health concerns for chemicals based on their chemical 
characteristics and estimated exposure. It is applicable to substances for which the 
chemical structure is known but for which there are few or no relevant toxicity data. The 
classification of chemicals according to their chemical structure is an essential 
component of the current TTC approach (Cramer classes, Cramer et al., 1978, Munro et 
al., 1996). It was first developed for substances in food contact materials. EFSA's 
Scientific Committee (2012) investigated the applicability of the TTC approach for its 
own work (i.e. food-related risk assessments) and recommended a revision and 
refinement of the Cramer Classes and underlying database. Nevertheless, the Cramer 
classification scheme is considered conservative and protective of human health (EFSA's 
Scientific Committee, 2012). EFSA's Scientific Committee has identified several cases 
where the TTC approach should not be applied, one of them being "mixtures of 
substances containing unknown chemical structures". 
In their opinion on the "Toxicity and Assessment of Chemical Mixtures" (SCHER, SCCS, 
SCENIHR, 2012), the Scientific Committees discussed the application of the TTC 
approach in the assessment of mixtures. They recommend the TTC approach could be 
used at a screening level for comparing first estimates of combined exposure to the TTC. 
For representative substances in assessment groups where data on limit values are 
missing, QSAR predictions, read-across, or the TTC approach could be used to fill the 
data gaps. A TTC-like approach can be used to eliminate combinations that are of no 
concern, if conservative exposure concentrations are used. 
Exemplary case studies exist in the literature where the TTC approach was used to 
assess human health risk from chemical mixtures in surface water. Price et al. (2009) 
explored the use of the TTC approach for the evaluation of the chronic non-carcinogenic 
effects of hypothetical and actual examples of chemical mixtures and it proved to 
provide conservative estimates of mixture toxicity. They therefore propose to use the 
TTC in screening assessments of mixtures where compound specific data for components 
of a mixture are missing. Along these lines, also Boobis et al. (2011) showed the 
application of the TTC approach in a Tier 0 risk assessment with the intention to 
prioritize the need for further evaluation of chemical mixtures. Data were based on 
surface water monitoring data in order to create a hypothetical mixture of 10 compounds 
from different classes (fragrances, pesticides, surfactants, personal care products, 
solvents, petrochemicals). They applied some worst case assumptions (i.e. direct 
consumption of surface water without treatment and investigating lifelong chronic 
exposure at maximum detected levels). The TTC using ToxTree and the concentration 
addition based Hazard Index were applied. In the specific case, no risk was identified. 
The case study confirmed the utility of using the TTC approach at Tier 0 as suitable tool 
for mixture assessments. Terry et al. (2015) showed the application of the TTC approach 
for facilitating the risk assessment of parent substances and their environmental 
metabolites using a pesticide as an example. The TTC approach was used for some 
metabolites with low predicted concentrations. Utilizing information on mode of action, 
relative potency, hazard characterisation, read across, predicted exposure and TTC 
provided a robust database minimizing animal use for the assessment. 
In summary, the TTC approach provides a useful tool to be used at lower tiers in the 
assessment of mixtures, providing limit values for mixture components with missing 
information. It is currently limited to its application in the area of human health. 
However, an international activity is currently ongoing to develop the ecoTTC approach 
for environmental hazard assessment, which is based mainly on aquatic toxicity data 
(Belanger et al. 2015).  
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3.9. Integrated Approach to Testing and Assessment (IATA) 
With the more regular use of new techniques like e.g. in vitro testing, omics approaches, 
computational methods, there is a need to develop strategies for evaluating the data 
generated and interpret them in a joint approach. There is also a need to strategically 
direct testing efforts in order to save resources. Efforts for developing such strategies 
are ongoing in various fora and usually include a framework to integrate test and non-
test information in a weight of evidence approach. Under the OECD, these approaches 
are called Integrated Approaches to Testing and Assessment (IATA). They "integrate 
existing knowledge based on classes of chemicals with the results of biochemical and 
cellular assays, computational predictive methods, exposure studies, and other sources 
of information to identify requirements for targeted testing or develop assessment 
conclusions. In some cases, the application of IATA could lead to the refinement, 
reduction, and/or replacement of selected conventional tests (e.g., animal toxicity 
tests)." (NAFTA, 2012). 
The development of IATA is nowadays strongly linked to the development and 
availability of AOPs. The AOPs offer the biological framework to build around the testing 
and assessment strategy (Tollefsen et al., 2014). A testing and data interpretation 
strategy can be developed by addressing MIEs and KEs in an AOP.  
Related testing strategies can follow a battery approach (all tests performed and results 
collected), sequential or tiered approaches (results are collected in a given sequence and 
further testing is stopped when sufficient information is available), or result-driven 
further testing approach (depending on results next most valuable testing is decided). 
The integration of results from the different information sources can occur at different 
levels, i.e. form raw data to summary/category level. Different approaches 
(deterministic, decision trees, scoring approaches etc.) can be applied (Tollefsen et al., 
2014). 
IATA provide another framework to collect information on individual mixture components 
as well as on whole mixtures, allowing a more structured (and if AOP based more 
mechanistically relevant) way of data generation and interpretation.  
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4. Status of current mixture risk assessment based on a 
dedicated expert survey 
In order to gain an overview of the current practices and experiences with assessing 
effects and risks from combined exposure, a survey among experts in authorities, 
academia and industry was performed. The online survey was published in the EU survey 
platform (https://ec.europa.eu/eusurvey/) on 23/01/2015 and closed on 23/03/2015. 
The link to the survey was sent to experts in the field that were identified in the 
following ways: (1) from scientific literature, (2) experts involved in developing the 
WHO/ICPS framework for combined exposure to chemical mixtures, (3) experts involved 
in developing the Opinion of the SCHER/SCHENIHR/SCCS on "Toxicity and Assessment 
of Chemical Mixtures", (4) participants of the recent EFSA Scientific Colloquium N°21 on 
"Harmonisation of human and ecological risk assessment of combined exposure to 
multiple chemicals", (5) representatives of the ongoing OECD project on combined 
exposure to multiple chemicals, (6) members of the EURL ECVAM Stakeholder Forum 
(ESTAF) and the PARERE expert network dedicated to the Preliminary Assessment of 
Regulatory Relevance of alternative test methods proposed for validation.  
The questionnaire contained the following sections: 
• General information on the respondent 
• Experience with different approaches for the assessment of mixture toxicity 
• Expert opinions regarding the use of specific approaches for mixture toxicity 
assessment 
• Views on the use of novel tools for the assessment of mixture toxicity 
• Comments on existing frameworks for the risk assessment of combined exposure 
to multiple chemicals 
• Possibility to provide references or files regarding relevant projects, publications, 
case studies. 
 
4.1. Information on respondents 
Fifty-eight valid responses were received and evaluated. Responses were received from 
48 experts from 16 different EU countries and 10 experts from 5 non-EU countries 
(Figure 1). Survey participants represented experts from academia, authorities, and 
industry in nearly equal parts (Figure 2). Participants had experience in the following 
sectors: chemicals (multiconstituent and UVCB substances under REACH), plant 
protection products, biocides, pharmaceuticals, cosmetics, food or feed additives, food or 
feed contaminants, surface water, drinking water, waste streams, soil, air, medical 
devices, alloys, botanicals, cigarette smoke, landfill leachate, solid waste from industrial 
combustion processes, tobacco toxicants, jewellery, toys, food contact materials, and 
sewage sludge. 
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Figure 1 Country of Respondent. Survey participants were from 16 different EU 
countries and 5 non-EU countries (indicated as "Other": Canada, Japan, Norway, Serbia, 
Switzerland, US). 
 
Figure 2 Survey respondents' affiliation 
4.2. General experience with mixture toxicity/risk assessment 
The majority of the respondents (48) had performed risk assessment(s) for chemical 
mixtures in the area of human health risk assessment (HRA) or environmental risk 
assessment (ERA) (Figure 3). Those that replied yes (i.e. had already performed mixture 
risk assessment) indicated that they had mainly assessed chemical mixtures in the 
context of the authorisation of commercial products and research & development (Figure 
4).  
2 3
2
3
4
1
5
17
22
2
1
3
10
10
Country of respondent
Austria Belgium
Denmark France
Germany Greece
Italy Latvia
Netherlands Portugal
Romania Slovenia
Spain Sweden
United Kingdom Other
16
173
20
2
Type of Affiliation
Academia
Authority
Consultancy
Industry
Other
  
 
24
 
Figure 3  Replies to the question "Did you ever need to perform a risk assessment of 
chemical mixtures for HRA or ERA?" 
 
Figure 4 Replies to the question "For which purpose(s) did you assess the overall 
toxicity of chemical mixtures?" Other purposes indicated were 1) development of CEFIC 
MIAT conceptual framework and CLP workplace monitoring. 
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4.3. Experience with the whole-mixture and component-based 
approaches 
Those participants having experience in performing mixture risk assessments (i.e. that 
answered "yes" to the question in Figure 3) were asked about their experience in 
applying whole mixture and component-based approaches for assessing intentional and 
unintentional mixtures (Figure 5). They further specified for which type of commercial 
product (intentional mixture) or sample (unintentional mixture) they applied such 
approaches (Figure 6) and which kind of component-based approaches they are mostly 
using (Figure 7). 
 
Figure 5 Experience in performing mixture risk assessments using whole mixture or 
component-based approaches applied to intentional or unintentional mixtures. 
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Figure 6 Replies to the question "For which type of mixture(s) have you applied a whole 
mixture or component-based approach?" Chemicals were further specified in the survey 
as "multiconstituent or UVCB substances under REACH". Other types of mixtures 
mentioned were medical devices, alloys, botanicals, food ware materials, jewellery, toys, 
cigarette smoke/tobacco toxicants, human tissue extracts, landfill leachates, solid waste 
from industrial combustion processes, sewage sludge. 
Respondents were asked which kind of tests they used for the whole-mixture and 
component based approaches for assessing intentional and unintentional mixtures. A 
wide range of tests reflecting all major tests usually used in single substance testing was 
mentioned. 
Experts were further asked about their experiences with different component-based 
approaches. The approaches most frequently used by the participating experts are the 
direct application of the Concentration Addition (CA) equation, the Hazard Index (HI) as 
well as Toxic Equivalency Factor (TEF) (Figure 7). Concentration Addition based 
approaches seem much more wide spread than independent action (IA) based 
predictions. 
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Figure 7 Replies to question "How often have you used the following component-based 
approaches?" (CA=concentration addition, TUS=Toxic Unit Summation, TEF=Toxic 
Equivalency Factor, RPF=Relative Potency Factor, PODI=Point of Departure Index, 
HI=Hazard Index, HI(int)=Hazard Index including interactions, MCR=Maximum 
Cumulative Ratio, IA=Independent Action) 
Experts could also provide information on additional component-based approaches they 
are using. For example, ADIadjusted, AOELadjusted, ARfDadjusted (based on common 
target organ/common toxicity; use of biotic ligand models (BLM); use of TTC and Margin 
of Safety (MoS) were mentioned. 
Experts were then asked about their experience with other approaches not fitting into 
the CA or IA category. Some examples mentioned were that mixtures were assessed and 
toxicity related to the main two constituents; effect-directed fractionation (e.g. toxicity 
identification evaluation TIE) for identifying most potent components in a mixture; 
approaches based on TKTD modelling, to assess dynamic effects of mixtures over time; 
history of safe use via well-established dietary intakes. These additional approaches 
were mainly used for research and development purposes. 
4.4. Expert opinions on mixture toxicity assessment 
Experts were asked about their opinions on mixture toxicity assessment. Experts gave 
their view on priority mixtures (Figure 8). Chemicals under REACH and plant protection 
products were mentioned most often. Experts were further asked whether they see a 
need to address interactions (e.g. synergisms/antagonisms) in the mixture risk 
assessment. Multiple options with possible reasons to take combination effects into 
account or not were given in the survey. Interestingly, several experts selected yes and 
no options together. The overall picture can be found in Figure 9. Among the experts 
that selected the "other" option, the main reasoning provided in the free text option was 
that interactions are considered rare, especially at low/environmental concentrations. 
However, most experts agreed that interactions should be taken into account on a case-
by-case basis and one expert proposed to look at interactions especially in the case of 
active substances like plant protection products, biocides, pharmaceuticals. 
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Figure 8 Replies to the question "Which type of mixture(s) or samples would you 
identify as highest priority for risk assessment that needs to take mixture effects into 
account?" divided by stakeholder group. Chemicals were further specified in the survey 
as "multiconstituent or UVCB substances under REACH". Other mixtures of importance 
mentioned were those present in human tissues and container systems. 
 
Figure 9 Replies to the question "Based on your experience or knowledge about the toxicity 
of mixtures, do you consider it important to include interactions (e.g. potential synergism or 
antagonism) in the assessment?" divided by stakeholder group. Among the experts that 
selected the "other" option, the main reasoning provided in the free text field was that 
interactions are considered rare, especially at low/environmental concentrations. However, 
most experts agreed that interactions should be taken into account on a case-by-case basis 
and one expert proposed to look at interactions especially in the case of active substances 
like plant protection products, biocides, pharmaceuticals. 
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Experts were asked about approaches that they consider particularly valuable or have 
abandoned based on their experience as well as information on software tools and 
databases relevant to assessing mixture effects (Figure 10). 
 
Figure 10 Replies to the questions on approaches the experts have abandoned due to 
negative experience, specific approaches that the experts would recommend for further 
considerations, and on use of relevant software tools and databases. 
The approach being mentioned most often as being abandoned was mainly Independent 
Action with the general reason that it is too data demanding. Specific approaches that 
were recommended for more extensive use were the MCR approach (Price and Han, 
2011), mixture toxic pressure approach (e.g. De Zwart and Posthuma, 2006), whole 
mixture testing at human relevant levels, use of TTC, in vitro methods, TKTD and DEB 
modelling. Software tools and databases mentioned of use for carrying out mixture 
assessments were CREME, CARES, MIXTOX, DEBtox, ToxTree, DEREK, Acropolis tool 
MCRA, US EPA BMDS, ToxCalcMix, Metals Classification Tool MeClas.  
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4.5. Use of novel tools in mixture toxicity assessment 
Experts were asked about the use of novel tools in the assessment of mixtures. An 
overview of the general responses regarding their use can be found in Figure 11. 
 
Figure 11 Replies to the question "Do you apply in vitro tools/omics approaches/ 
(quantitative) structure activity relationships ((Q)SARs)/ read-across/ physiologically 
based pharmacokinetic (PBPK) modelling/ the toxicological threshold of concern (TTC) 
concept/ Adverse Outcome pathways (AOPs)/ dynamic energy budget (DEB) models for 
human health risk assessment (HRA), environmental risk assessment (ERA) or both?" 
Experts were then asked further on their reasons for using specific tools or not using 
them. Results are presented in the following sections 4.5.1-4.5.9. 
4.5.1. Use of in vitro assays in mixture toxicity assessment 
In vitro tools are increasingly applied, both in human and environmental risk 
assessment. Not only because they are powerful tools to investigate TK processes, but 
also because they can provide key information on the mechanism of action. Especially 
with complex mixtures like environmental samples, they might provide insight in toxicity 
beyond the traditional chemical analysis. 
28 experts replied that they use in vitro assays in the assessment of mixtures. The tests 
mentioned were tests from the OECD endocrine disruptor testing framework, cell-based 
transactivation assays, irritation/sensitisation assays, epiocular assay, dermal 
absorption, Ames test, micronucleus assay, genotoxicity, mutagenicity, comet assay, 
ROS production, cytotoxicity, microtox, algae assays, zebrafish embryo tests, bacterial 
reporters, rodent and human cell lines and human tissue cultures.  
The reasons for using in vitro assays are presented in Figure 12. Among the other 
reasons, one expert replied that the use of in vitro tools combined with PBPK modelling 
is the way forward for chemical risk assessment. Other 28 experts replied that they are 
not using in vitro assays and were asked for the reason(s) (Figure 13). The main reasons 
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for not using in vitro methods are the lack of legal drivers and lack of guidance and 
validation. 
 
 
Figure 12 Replies to the question "What are the main reasons you are using these in 
vitro assays?" Other reasons mentioned were for research purpose, Ames test because it 
is a data requirement in some regions, and combination of in vitro testing with PBPK 
modelling is seen as the way forward for chemical risk assessment. 
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Figure 13 Replies to the question "What are the main reasons you are not using in vitro 
assays? The main "other reasons" given were lack of EU guidance and validation, and in 
the case of cosmetics that in vitro tests are less relevant for the final products as clinical 
tests are performed with cosmetic formulations. 
4.5.2. Use of omics approaches in mixture toxicity assessment 
Omics technologies are increasingly applied to gain insight in the mechanism of action of 
compounds and mixtures, at the transcription level (transcriptomics), the protein level 
(proteomics) or even the whole metabolome (metabolomics). Genomic tools can 
potentially be used also to investigate differences in responses between individuals and 
species. 
10 experts had experience with using omics tools in mixture risk assessment. Most 
experience is available for transcriptomics, and to a lesser extent with proteomics and 
metabolomics (Figure 14). The main reasons for using omics technologies are presented 
in Figure 15. The main advantages mentioned were the possibility to study overall 
effects and ability to gain mechanistic information as well as the sensitivity of the 
methods. 46 experts replied they were not using omics technologies for mixture risk 
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assessment. The main reasons for not using omics are presented in Figure 16, with one 
of the main problems identified being the lack of clear guidance and protocols. 
 
Figure 14  Replies to the question "Which type of omics technologies are you using?" 
 
Figure 15 Replies to the question "What are the main reasons you are using omics 
based approaches?" The other reasons given were the possibility to study mechanisms of 
action. 
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Figure 16  Replies to the question "What are the main reasons you are not using omics 
based assays?" The main "other reason" provided was the unavailability of the relevant 
practical tools in the facilities of the responding experts, as well as the lack of clear 
guidance. 
4.5.3. Use of (Q)SAR models in mixture toxicity assessment 
(Quantitative) structure activity relationship ((Q)SAR) models are mathematical models 
that have been developed to predict a number of physico-chemical and (eco)toxicological 
properties of chemicals without performing in vitro or in vivo tests. The models use 
information on the structure of the chemical, and combine this with a database with 
toxicological information on related/comparable chemicals. 
25 of the participating experts are using (Q)SAR in the mixture risk assessment. They 
consider (Q)SARs very useful because they represent an alternative to in vivo studies to 
some extent and they can serve for prioritising experimental testing, and results are 
quickly available (Figure 17). The purposes for which the experts apply (Q)SAR methods 
are shown in Figure 18 with the main purpose being hazard identification. The endpoints 
for which (Q)SARs are mainly used are endocrine activity in cell based transactivation 
assays, mortality, reprotoxicity, acute (eco)toxicity, mutagenicity, genotoxicity, cancer 
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alerts, skin sensitisation, toxicokinetics, secondary poisoning, logKow, logKoc, BCF, 
biodegradation, fate and behaviour. Experts were also asked to provide information on 
the QSAR tools they are using (Figure 19). 
30 experts replied that they are not using QSARs for mixture assessments. The main 
reasons for not using (Q)SARs are presented in Figure 20. 
 
Figure 17 Replies to the question "What are the main reasons you are using (Q)SARs?" 
"Other reasons" mentioned were the application to metabolites and impurities where no 
data are available, and the possibility to identify substances of concern and drive further 
experimental testing. Also the use for chemical fate aspects was mentioned.  
 
Figure 18 Replies to the question "For what purpose are you applying (Q)SARs? "Other 
reasons" mentioned were data gap filling, prediction of physic-chemical properties, 
grouping of metabolites and impurities, and fate predictions.  
14
13
12
6
4
0 5 10 15
The results are quickly available
The method can replace in vivo testing (to
some extent)
The method is cost efficient
The mechanism of action considered has a
clear in vivo relevance
Other reason(s)
What are the main reasons you are using (Q)SARs?
21
9
7
5
5
0 5 10 15 20
Hazard identification
Priority setting
Mode of Action identification
Exposure assessment
Other
For what purpose(s) are you applying (Q)SARs?
  
 
36
 
Figure 19 Replies to the question "Which (Q)SAR models do you apply?" Other models 
mentioned were DEBtox, VEGA platform models, ACD Labs Percepta, Episuite, SarPy. 
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Figure 20 Replies to the question "What are the main reasons you are not using 
(Q)SARs?". The main "other reasons" given were that databases are not validated, lack 
of guidance, (Q)SARs are applied to single substances but not to mixtures because only 
qualitative QSAR information is used, (Q)SARs are not relevant because of available 
testing information (e.g. for PPPs), too many uncertainties associated with (Q)SARs, lack 
of knowledge/training. 
4.5.4. Use of read-across approaches in mixture toxicity 
assessment 
Read-across is a technique for predicting endpoint information for one substance by 
using data on the same endpoint from (an)other substance(s). This can be performed 
with a limited set of substances (analogue approach) or within a large group of 
substances (category approach). 
28 experts replied that they are using read-across in the assessment of mixtures. The 
main reason given for using read-across was to replace in vivo testing to some extent 
(Figure 21). Regarding the endpoints for which read-across is applied, experts were 
mostly answering that they use read-across for any kind of endpoint where 
needed/information is suitable and where read-across is accepted by ECHA for REACH 
assessments. Endpoints mentioned include the whole spectrum of short and long-term 
animal study endpoints, as well as ecotoxicity. 27 experts replied they are not using 
read-across approaches, mainly because of lack of expert knowledge (Figure 22). 
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Figure 21 Replies to the question "What are the main reasons you are using a read-
across approach?" Main "other reasons" were that read-across is a useful tool for the use 
for metabolites and impurities, where toxicity information is limited, it is encouraged 
under REACH, can be used to support in vitro test results and refine experimental 
design. 
 
Figure 22 Replies to the question "What are the main reasons you are not using a read-
across approach?" Main "other reasons" given were a lack of guidance and validation. 
4.5.5. Use of PBTK modelling in mixture toxicity assessment 
Physiologically based (PB) models are used for modelling toxicokinetic (TK) processes 
(PBTK) or TK and toxicodynamic (TD) processes (PBTKTD). The PBTK models are 
especially useful to assess hazard, as they provide a quantitative means to address TK 
processes. PBTKTD models link the TK and TD dimension and therefore are generally 
more complex. 
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12 experts replied that they are using PBTK modelling in the assessment of mixtures. 
The main reasons for using PBTK models were the replacement of in vivo testing to a 
certain extent, since PBTK models allow relating in vitro experiments to in vivo internal 
exposures (Figure 23). The main purpose for which PBTK modelling is used in mixture 
assessment is to correlate in vitro concentrations to in vivo scenarios/to link internal and 
external dose, to identify TK interactions, to understand metabolite generation, species 
comparison, route of exposure, assess effects of intermittent exposure often mentioned 
in the context of PPPs. 
 
 
Figure 23 Replies to the question "What are the main reasons you are using a PBTK 
model?" The main "other reasons" were to study mechanisms, study mechanisms by 
which mixtures affect life-history traits, assess intermittent exposures 
 
Figure 24 Replies to the question "What are the main reasons you are not using a PBTK 
model?" The main "other reasons" given were lack of knowledge/expertise/training, lack 
of guidance and tackling related uncertainties. 
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41 experts are not using PBTK modelling for mixture assessments. The main reason for 
not using PBTK modelling is a lack of knowledge/training as well as the lack of many 
input parameters (Figure 24). 
 
4.5.6. Use of the TTC approach in mixture toxicity assessment 
The approach of the threshold of toxicological concern (TTC) is based on historical 
toxicological data, that show empirically that there is a threshold below which toxicity 
does not occur (for non-cancer effects) or likelihood of tumour incidence is negligible 
(cancer effects). There are thresholds derived for different classes of compounds 
(Cramer classes). 
22 experts replied that they apply the TTC approach in the assessment of mixtures. The 
main reason is that it can allow the waiving of additional testing (Figure 25). 33 experts 
are not using the TTC approach with the main reason being that it was developed for 
human health assessments and not for environmental assessments (Figure 26). 
 
Figure 25 Replies to the question "What are the main reasons you are using the TTC 
approach?" Main "other reasons" were the availability for chemicals without chronic data, 
the use to identify and prioritise testing needs, avoiding testing, and application to 
ingredients of biological origin and residual impurities.  
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Figure 26 Replies to the question "What are the main reasons you are not using the 
TTC approach?" Main "other reasons" were the need of updating the TTC approach, the 
lack of experience, and dealing with higher substance concentrations. 
4.5.7. Use of AOPs in mixture toxicity assessment 
An Adverse Outcome Pathway (AOP) is an analytical construct, describing a sequential 
chain of causally linked events at different levels of biological organisation that lead to 
an adverse health or ecotoxicological effect. AOPs might provide insight into the 
relevance of combinational effects when assessing the toxicity of mixtures. 
12 experts replied that they are using AOPs in the assessment of mixtures. The main 
reasons for applying AOPs were that the method shows insight into potential interactions 
and that the considered mechanisms have a clear in vivo relevance (Figure 27). 43 
experts are not applying AOPs with the main reason being the limited availability of 
relevant, sufficiently developed AOPs (Figure 28). 
 
Figure 27 Replies to the question "What are the main reasons you are using an AOP 
approach?" The "other reason" mentioned was to explore its potential for risk 
assessment. 
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Figure 28 Replies to the question "What are the main reasons you are not using an AOP 
approach?" The "other reasons" mentioned are mainly the lack of expertise/experience, 
and difficulties to implement this new concept in risk assessment. 
4.5.8. Use of DEB models in mixture toxicity assessment 
Dynamic Energy Budget (DEB) models aim to identify (simple) quantitative rules for the 
processes of uptake of substrate by organisms and the use for maintenance, growth, 
maturation and reproduction. By linking a TK model to the DEB, effects of chemicals can 
be incorporated as well. 
8 experts replied they are using DEB models in the assessment of mixtures with the 
main reason being the inclusion of multiple stressors, the ecological relevance, and the 
in vivo relevance (Figure 29). 47 experts were not using DEB models with the main 
reason being on the one hand that it is a concept usually applied in ecotoxicology rather 
than for human health assessments and on the other hand the lack of expertise and the 
lack of validation (Figure 30). 
 
Figure 29 Replies to the question "What are the main reasons you are using DEB 
models?" The "other reason" was stating that DEB models are the most promising 
approach to interpret and predict effects of stressors on growth and reproduction and to 
learn from experimental testing. 
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Figure 30 Replies to the question "What are the main reasons you are not using DEB 
models?" Main "other reasons" were a general lack of expertise/experience, for experts 
in human RA its focus on environmental RA, and a lack of validation. 
4.5.9. Use of IATA frameworks in mixture toxicity assessment 
IATA provide a framework to integrate existing knowledge based on classes of chemicals 
with the results of biochemical and cellular assays, computational predictive methods, 
exposure studies, and other sources of information to identify requirements for targeted 
testing or develop assessment conclusions. 
8 experts had experience in applying IATA frameworks to the assessment of mixtures 
(Figure 31). The IATA mentioned are skin and eye irritation, integrated testing strategies 
(ITS) described in the ECHA guidance and some tailored customised approaches.  
 
Figure 31 Replies to the question "Do you use any IATA framework for the assessment 
of mixtures?" 
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4.5.10. Summary on the use of novel tools in the assessment of 
mixtures 
Many experts are already using several of the new tools. Some are still more frequently 
used as research activity, but start being applied also in regulatory context. Many tools 
are considered as promising but not yet ready for regulatory purposes. Often mentioned 
reasons for not applying novel tools are the lack of legal drivers, lack of standardisation / 
validation, lack of guidance, and a lack of expertise.  
 
4.6. Frameworks for the risk assessment of combined exposure 
to multiple chemicals 
Several international frameworks for addressing combined exposure to chemical 
mixtures were developed in recent years. Experts were asked in the survey about their 
experience with the most widespread three frameworks, i.e. the WHO/IPCS framework 
(WHO/IPCS 2009, Meek et al 2011), Proposal by the three non-food scientific 
committees of the European Commission (SCHER, SCENIR, SCCS, 2012), and the 
proposal by CEFIC MIAT (Price et al., 2012). 35 experts were familiar with at least one of 
the three frameworks. Most experience was shown for the WHO/IPCS framework (Figure 
32). 
 
Figure 32 Replies to question "Which [international] framework(s) [for addressing 
combined exposure] do you apply?" 
Experts were then asked to provide feedback on their experience with the above-
mentioned frameworks. The experiences were generally positive. The main limitation 
mentioned especially for the WHO/IPCS and the SCHER/SCENIHR/SCCS framework is 
that they provide a more conceptual framework and less practical guidance. 
The experts commented positively on the WHO/IPCS, rating it an easy and transparent 
approach. Critics were that it is rather general and lacks criteria when refinement should 
be stopped. The data available usually allow only to perform Tier 1 and 2 assessments 
and not to go to higher tiers. However, it was appreciated that Tier 0 and Tier1 can 
usually be performed with the data available.  
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The SCHER, SCENIHR, SCCS framework is considered useful for organising data and 
deciding how to perform the assessment, but it is more conceptual and provides limited 
guidance on refined assessments.  
The CEFIC MIAT framework was judged as useful since it comprises practical tools. Most 
input received on this framework was from experts involved in its development. 
Experts were then asked about other frameworks they are applying for assessing 
combined exposure. 15 experts replied they had experience with other frameworks, 40 
replied to have no experience with other frameworks (Figure 33). The most often 
mentioned example was the cumulative assessment for plant protection products as 
developed by EFSA (EFSA PPR Panel, 2013). Furthermore, experts mentioned the US 
EPA, transitional guidance on mixture toxicity assessment of biocidal products (2014); 
EFSA guidance on Birds and Mammals (2009); Backhaus and Faust 2012 (Environ. Sci. 
Technol., 46 (5)); UK Combined toxicity assessment for plant protection products (non-
dietary and dietary risk assessment); Methodology and the information to be specified 
for the assessment of pesticides used in tank-mixtures subject to prior assessment in 
accordance with the French Ministerial Order of 7 April 2010; Metals Classification tool 
(MeClas)/Transformation Dissolution Protocol. 
 
Figure 33 Replies to the question "Are you familiar with or do you apply any other 
framework to assess the toxicity of mixtures?" 
 
4.7. General/additional remarks by experts in the survey 
In the end of the questionnaire, experts had the possibility to add some general remarks 
or provide additional information in the form of references or uploading files. Experts 
were providing many useful references. 
 
4.8. Conclusions from the expert survey 
The expert survey was a success with 58 experts participating and providing extensive 
information in the free text fields. The results from the survey allow to derive a clear 
picture on the current status of assessing mixtures.  
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The main sectors where most experience is already gained in assessing mixtures are in 
the area of plant protection products and chemicals. These were also rated highest 
regarding the priority for performing mixture assessments. However, mixture 
assessments are also performed in many other areas. 
Experts have experience with the whole mixture as well as the component-based 
approaches applying them to both, intentional and unintentional mixtures. 
Mostly concentration addition (CA) based methods are used for predicting mixture 
effects. In contrast, several experts would not recommend the further use of 
independent action (IA) based approaches, mainly because of the higher need for input 
data for IA and considering the small differences in predictions by IA compared to CA. 
Experts were asked about their opinion on considering interactions. Most experts stated 
that interactions should be considered if there is specific evidence for interactions and on 
a case-by-case basis. 
Regarding the use of novel tools in the risk assessment of mixtures (such as in vitro 
methods, omics, (Q)SARs, read-across, PBTK modelling, TTC approaches, AOPs, DEB 
models, IATA), expert opinions are split between those applying them (often more in a 
research context) and those that generally think these tools are valuable but their use is 
currently limited because of lack of guidance, lack of data, or lack of expertise. 
Experts had experience with assessing mixtures, both in the context of human health 
and environmental risk assessment. Apart from some tools that were developed for a 
specific application in HRA (e.g. TTC approach) or ERA (e.g. DEB modelling), there 
seems to be no clear difference in the opinions/experiences provided. 
A general need for clear and harmonised guidance for combined exposure assessments 
can be identified from the survey. 
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5.  Conclusions 
Humans and the environment are continuously exposed to a multitude of substances via 
different routes of exposure. However, the risk assessment of chemicals for regulatory 
purposes does not generally take into account the “real life” exposure to multiple 
substances, but mainly relies on the assessment of individual substances. A previous 
review on regulatory requirements for the assessment of mixtures shows that combined 
exposure is nowadays taken up in several pieces of legislation, however a harmonised 
consistent approach on performing mixture assessments across different regulatory 
sectors is still lacking (Kienzler et al., 2014). 
Assessment in different sectors 
Our expert survey showed that mixture risk assessment is taken up in various fields. The 
main sectors where most experience is already gained in assessing mixtures are in the 
area of plant protection products (PPPs) and chemicals falling under REACH, which is 
however also linked to the fields of work of the respondents. PPPs and chemicals under 
REACH were also rated highest regarding the priority for performing mixture 
assessments by the experts. The survey respondents seemed to rate active substances 
(such as biocides, plant protection products and pharmaceuticals) overall of higher 
concern, also regarding a potential presence of interactions (i.e. including the risk of 
synergistic effects). However, mixture assessments are also performed in many other 
areas. Looking at the available experience derived through the survey and at case 
studies in the literature (Kienzler et al., unpublished report), many examples can be 
found where environmental exposure or occupational exposure to mixtures were 
retrospectively assessed, based on monitored exposure data. Examples in the 
prospective risk assessment are rarer. One major achievement in this area is 
represented by the cumulative risk assessment and respective cumulative assessment 
groups as developed by EFSA's PPR Panel (EFSA PPR, 2014). Further development of 
consistent approaches for prospective risk assessment is still needed. 
Component-based assessment approaches: concentration addition vs independent action 
Currently, many experts have experience with the whole mixture as well as the 
component-based approaches applying them to both, intentional and unintentional 
mixtures, without a clear trend in their combination. Regarding component-based 
approaches, survey respondents mostly use concentration addition (CA) based methods 
for predicting mixture effects. Several experts would even not recommend the further 
use of independent action (IA) based approaches, mainly because of the higher need for 
input data for IA and considering the small differences in predictions by IA compared to 
CA. Overall, evidence in the literature supports the application of concentration addition 
as a first, protective approach. It is therefore also the default approach to start from in 
several international recommendations and frameworks, independent of components' 
similar or dissimilar mode of action. However, once a detailed risk assessment for a 
mixture is performed, relevant groupings will be based on common target organs and/or 
MoA (e.g. based on AOPs). The choice of the approach used depends strongly on the 
context of the risk assessment as well as on the information on which to base the 
grouping of components. Irrespective of the starting point for grouping, it is 
recommended to use all available information on the mixture and its components: 
physico-chemical properties, structural alerts, (Q)SAR and read-across information, 
evidence from omics, in vitro (high throughput screening or other) or in vivo 
experimental data, depending on availability. 
Considering interactions in mixture assessments 
Current evidence in the literature suggests that interactions (synergistic or antagonistic 
effects) at lower concentration levels such as environmental concentrations are rare and 
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if observed, leading to deviations from CA predictions that are relatively small. In the 
survey, experts were asked about their opinion on considering interactions. Most experts 
stated that interactions should be considered if there is specific evidence for interactions 
and on a case-by-case basis. Experts commented that the highest potential for 
interactions should be assumed for active substances (such as PPPs, biocides, 
pharmaceuticals). Some experts answered that they consider interactions rare and 
hazard sufficiently covered using CA based approaches. Only very few experts agreed to 
introduce a default safety factor to cover potential interactions, which is sometimes 
proposed in the literature (for overview see Backhaus, 2015). However, more knowledge 
could be gained from additional case studies covering different sectors to further 
underpin this. 
To address and predict interactions, toxicokinetic and toxicodynamic modelling are 
valuable tools. PBTK and DEB modelling can support gaining further mechanistic 
understanding and looking at effects of individual chemicals in a mixture in an integrated 
approach. Toxicokinetic information to feed into these models, can be gained e.g. from 
in vitro studies. Also read-across information from similar mixtures can be used to 
identify mixtures where interactions could play a role and should be further investigated. 
Application of "novel tools" in the assessment of mixtures 
In this report the current state of the art of the application of alternative tools for 
assessing the hazard of chemical mixtures was briefly reviewed. The focus is hereby on 
the adverse outcome pathway (AOP) concept, in vitro methods, omics techniques, in 
silico approaches such as quantitative structure activity relationships (QSARs) and read-
across, toxicokinetic and dynamic energy budget (DEB) modelling, and on integrated 
approaches to testing and assessment (IATA). A brief summary of the main possibilities 
for the application of each of these tools in the context of mixtures is given below: 
• AOPs are already used for the grouping of chemicals according to their MoA, which is 
an important step in the assessment of mixtures. Apart from this, they can help in 
putting results from in vitro tests and computational modelling into context, e.g. in 
developing AOP based IATA, that allow for the integration of different data types. 
• In vitro methods can support the assessment of mixtures in many ways, mainly in 
"whole-mixture testing" applied e.g. in effect-based environmental monitoring or in 
deriving relevant information on individual mixture components. Performing high-
throughput screening of many chemicals in many different assays enables the 
characterisation of chemicals regarding their MoA which can help e.g. in the grouping 
of chemicals. AOPs can help in integrating data from diverse in vitro tests that 
address different steps in a chain of biological events. If in vitro test results are 
interpreted in connection with toxicokinetic information, even quantitative 
information on potency can be derived. 
• The main potential of omics techniques (transcriptomics, proteomics, metabolomics) 
regarding the assessment of mixtures lies in the investigation of affected pathways 
for unravelling MoAs and investigating possible interactions, which can again support 
the grouping of chemicals. 
• QSAR models can be used to obtain information on the properties and activities of 
substances from chemical structure alone, and can thus be used to fill data gaps in 
the safety assessment of chemicals. There are three main ways in which QSARs can 
be applied for the assessment of mixtures: (1) for predicting (missing) information 
on individual compounds (physico-chemical properties, toxicological effects) (2) for 
predicting directly or stepwise the combined effects and interactions of chemicals in a 
mixture (3) for assessing whether chemicals will act in a similar or dissimilar way. 
• Read-across can be of value in the assessment of mixtures mainly in two ways, i.e. 
to predict missing information for untested constituents of a mixture in a component 
based approach, or to read-across for similar mixtures in a whole mixture approach. 
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• Toxicokinetics (TK) and toxicodynamics (TD) considerations can support the 
assessment of chemical mixtures in several ways with the main areas of application 
being (1) determination of internal exposure concentrations, e.g. enabling a relation 
between body concentrations and in vitro experiments (i.e. IVIVE, in vitro to in vivo 
extrapolations), of relevance for single chemicals as well as for chemical mixtures, 
(2) considering the simultaneous or sequential exposure to different mixture 
components, assessing the probability that those reach the same target, and (3) 
predicting interactions among mixture components on TK and TD level.  
• The approach of dynamic energy budgets (DEBs) is applied in the ecotoxicology area. 
For the time being DEB models are not yet regularly used in the assessment of 
mixtures. They are however a promising tool, since they look at effects in a more 
integrated and mechanistic way, potentially integrating chemical and non-chemical 
stressors. 
• The TTC approach is recommended in the literature for use at a screening level 
mixture assessment, for comparing first estimates of combined exposure to the TTC. 
It can serve eliminating combinations that are of low concern and to prioritise 
mixtures for further assessment. Currently, the TTC approach is limited to application 
in human health risk assessment; however, a corresponding ecoTTC approach is 
under development.  
• In the context of the risk assessment from combined exposure, IATA provide another 
framework to collect information on individual mixture components as well as on 
whole mixtures, allowing a more structured (and if AOP based more mechanistically 
relevant) way of data generation and interpretation.  
In the survey, expert opinions regarding these methodologies and tools were split 
between those applying them (often more in a research context) and those that 
generally think these tools are valuable but see their use as currently limited because of 
a lack of guidance, lack of data, or lack of expertise. 
 
Overall, a high potential in applying novel tools and scientific methodologies for the 
assessment of chemical mixtures can be identified. They allow deriving meaningful 
information on individual mixture components or whole mixtures, enabling a better 
understanding of the underlying mechanisms of mixture effects. Their main strengths lie 
in their integrated use and smart combination to put different aspects regarding the 
hazard from combined exposure to multiple chemicals into context. In order to benefit 
from these tools in the hazard assessment of mixtures, more guidance on their use is 
needed to facilitate a more widespread application. 
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